Madison Marquette Closes Merger with Real Estate Advisory Roseview.
19 July 2019 - Washington, DC, US-based real estate company Madison Marquette has closed its merger with Boston, US-based boutique institutional real estate and advisory company The Roseview Group to expand Marquette's national platform, the company said.
The two companies have reached a definitive agreement in March.
The combination continues Madison Marquette's strategic path forward in growing its platform-- bringing capital markets and corporate advisory capabilities to the company and augmenting Madison Marquette's full-service platform.
With the merger, Madison Marquette fortifies its full-service platform. Roseview's real estate fund management and investment track record, as well as its capital markets expertise raising equity for private real estate companies and investment managers, complements Madison Marquette's well-established reputation in real estate investment and management.
Roseview brings its corporate advisory practice, which provides value-added asset management services to corporations with complex real estate portfolios and under-utilised property holdings.
Madison Marquette is a private real estate investment manager, developer, operator and service provider headquartered in Washington, DC.
Madison Marquette partners with global, institutional and private investors to achieve investment performance across asset classes, including mixed-use, retail, office, medical, industrial, senior living and multi-family.
The Roseview Group has a team of 20 professionals and operates a national practice through offices in Boston (headquarters), Seattle, Philadelphia, and Western Michigan.
The company offers a range of real estate experience in entitlement, design, construction, development, acquisitions, financing, leasing, asset sales, asset management and corporate portfolio management.
Sector: Construction/Real Estate
Target: The Roseview Group
Buyer: Madison Marquette
Deal size in USD:
Type: Corporate Acquisition
Buyer advisor: , ,
Comment: Terms of the deal were not disclosed
|Printer friendly Cite/link Email Feedback|
|Publication:||M & A Navigator|
|Date:||Jul 19, 2019|
|Previous Article:||McDermott Will and Emery Acquires Farragut Square Group.|
|Next Article:||ImmunoCellular Therapeutics to Sell Remaining Preclinical and Clinical Programmes, IP.|